Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With New Power, New Problems: FDA Confronts Complications of Safety Labeling Change Authority

Oct 03 2011

• By Martin Berman-Gorvine

Related Content

FDA Flexes New FDAAA Muscle With ESA Safety Labeling - And May Help Tone Up Amgen’s Franchise

Jul 30 2008

Class-Wide Rx Safety Issues Are Focus Of FDA Guidance On New Label Change Powers

May 02 2011

Safety Labeling Change Order Letters

May 02 2011

Industry Seeks Power To Trigger Safety Labeling Changes Under FDAAA

Aug 08 2011

When Is An Adverse Event Not An Adverse Reaction?

Oct 03 2011

FDA Calls For Class-Wide REMS For LABA Asthma Drugs

Feb 22 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window